Functional advantages of dynamic protein disorder

FEBS Letters

Volumn 589, Issue 19, 2015, Pages 2433-2440

  Berlow, Rebecca B ^a   Dyson, H Jane ^a   Wright, Peter E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Coupled folding and binding; Post translational modification; Transcriptional activation

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 2; INTRINSICALLY DISORDERED PROTEIN; PROTEIN E7; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG; PROTEIN BINDING;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL STRESS; HUMAN; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; REVIEW; AMINO ACID SEQUENCE; CHEMISTRY; MOLECULAR GENETICS; MOLECULAR MODEL; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; HUMANS; INTRINSICALLY DISORDERED PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84942294146     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.06.003     Document Type: Review

References (113)

1. G.W. Daughdrill, M.S. Chadsey, J.E. Karlinsey, K.T. Hughes, and F.W. Dahlquist The C-terminal half of the anti-sigma factor, FlgM, becomes structured when bound to its target, sigma 28 Nat. Struct. Biol. 4 1997 285 291
2. R.W. Kriwacki, L. Hengst, L. Tennant, S.I. Reed, and P.E. Wright Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity Proc. Natl. Acad. Sci. USA 93 1996 11504 11509
3. A.K. Dunker, C.J. Brown, J.D. Lawson, L.M. Iakoucheva, and Z. Obradovic Intrinsic disorder and protein function Biochemistry 41 2002 6573 6582
4. V.N. Uversky Natively unfolded proteins: a point where biology waits for physics Protein Sci. 11 2002 739 756
5. P.E. Wright, and H.J. Dyson Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm J. Mol. Biol. 293 1999 321 331
6. L.M. Iakoucheva, C.J. Brown, J.D. Lawson, Z. Obradovic, and A.K. Dunker Intrinsic disorder in cell-signaling and cancer-associated proteins J. Mol. Biol. 323 2002 573 584
7. H.J. Dyson, and P.E. Wright Intrinsically unstructured proteins and their functions Nat. Rev. Mol. Cell Biol. 6 2005 197 208
8. R. van der Lee, M. Buljan, B. Lang, R.J. Weatheritt, G.W. Daughdrill, A.K. Dunker, M. Fuxreiter, J. Gough, J. Gsponer, D.T. Jones, P.M. Kim, R.W. Kriwacki, C.J. Oldfield, R.V. Pappu, P. Tompa, V.N. Uversky, P.E. Wright, and M.M. Babu Classification of intrinsically disordered regions and proteins Chem. Rev. 114 2014 6589 6631
9. J. Gsponer, and M.M. Babu The rules of disorder or why disorder rules Prog. Biophys. Mol. Biol. 99 2009 94 103
10. P.E. Wright, and H.J. Dyson Intrinsically disordered proteins in cellular signalling and regulation Nat. Rev. Mol. Cell Biol. 16 2015 18 29
11. T.J. Gibson Cell regulation: determined to signal discrete cooperation Trends Biochem. Sci. 34 2009 471 482
12. H.J. Dyson, and P.E. Wright Coupling of folding and binding for unstructured proteins Curr. Opin. Struct. Biol. 12 2002 54 60
13. P. Tompa, N.E. Davey, T.J. Gibson, and M.M. Babu A million peptide motifs for the molecular biologist Mol. Cell 55 2014 161 169
14. K. Van Roey, T.J. Gibson, and N.E. Davey Motif switches: decision-making in cell regulation Curr. Opin. Struct. Biol. 22 2012 378 385
15. K. Van Roey, B. Uyar, R.J. Weatheritt, H. Dinkel, M. Seiler, A. Budd, T.J. Gibson, and N.E. Davey Short linear motifs: ubiquitous and functionally diverse protein interaction modules directing cell regulation Chem. Rev. 114 2014 6733 6778
16. T. Mittag, J. Marsh, A. Grishaev, S. Orlicky, H. Lin, F. Sicheri, M. Tyers, and J.D. Forman-Kay Structure/function implications in a dynamic complex of the intrinsically disordered Sic1 with the Cdc4 subunit of an SCF ubiquitin ligase Structure 18 2010 494 506
17. P. Tompa, and M. Fuxreiter Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions Trends Biochem. Sci. 33 2008 2 8
18. P. Tompa, C. Szasz, and L. Buday Structural disorder throws new light on moonlighting Trends Biochem. Sci. 30 2005 484 489
19. N.E. Davey, K. Van Roey, R.J. Weatheritt, G. Toedt, B. Uyar, B. Altenberg, A. Budd, F. Diella, H. Dinkel, and T.J. Gibson Attributes of short linear motifs Mol. BioSyst. 8 2012 268 281
20. V. Neduva, and R.B. Russell Linear motifs: evolutionary interaction switches FEBS Lett. 579 2005 3342 3345
21. C.M. Gould, F. Diella, A. Via, P. Puntervoll, C. Gemund, S. Chabanis-Davidson, S. Michael, A. Sayadi, J.C. Bryne, C. Chica, M. Seiler, N.E. Davey, N. Haslam, R.J. Weatheritt, A. Budd, T. Hughes, J. Pas, L. Rychlewski, G. Trave, R. Aasland, M. Helmer-Citterich, R. Linding, and T.J. Gibson ELM: the status of the 2010 eukaryotic linear motif resource Nucleic Acids Res. 38 2010 D167 D180
22. M.E. McLaughlin-Drubin, and K. Munger The human papillomavirus E7 oncoprotein Virology 384 2009 335 344
23. A.L. Jansma, M.A. Martinez-Yamout, R. Liao, P. Sun, H.J. Dyson, and P.E. Wright The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb J. Mol. Biol. 426 2014 4030 4048
24. S. Chellappan, V.B. Kraus, B. Kroger, K. Munger, P.M. Howley, W.C. Phelps, and J.R. Nevins Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product Proc. Natl. Acad. Sci. USA 89 1992 4549 4553
25. C.J. Oldfield, Y. Cheng, M.S. Cortese, P. Romero, V.N. Uversky, and A.K. Dunker Coupled folding and binding with alpha-helix-forming molecular recognition elements Biochemistry 44 2005 12454 12470
26. A. Mohan, C.J. Oldfield, P. Radivojac, V. Vacic, M.S. Cortese, A.K. Dunker, and V.N. Uversky Analysis of molecular recognition features (MoRFs) J. Mol. Biol. 362 2006 1043 1059
27. J.C. Ferreon, C.W. Lee, M. Arai, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2 Proc. Natl. Acad. Sci. USA 106 2009 6591 6596
28. D.P. Teufel, S.M. Freund, M. Bycroft, and A.R. Fersht Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53 Proc. Natl. Acad. Sci. USA 104 2007 7009 7014
29. H. Feng, L.M. Jenkins, S.R. Durell, R. Hayashi, S.J. Mazur, S. Cherry, J.E. Tropea, M. Miller, A. Wlodawer, E. Appella, and Y. Bai Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation Structure 17 2009 202 210
30. C.W. Lee, M. Arai, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP Biochemistry 48 2009 2115 2124
31. C.W. Lee, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein Biochemistry 49 2010 9964 9971
32. L.M. Miller Jenkins, H. Feng, S.R. Durell, H.D. Tagad, S.J. Mazur, J.E. Tropea, Y. Bai, and E. Appella Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex Biochemistry 54 2015 2001 2010
33. P.H. Kussie, S. Gorina, V. Marechal, B. Elenbaas, J. Moreau, A.J. Levine, and N.P. Pavletich Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain Science 274 1996 948 953
34. G.M. Popowicz, A. Czarna, and T.A. Holak Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain Cell Cycle 7 2008 2441 2443
35. E. Bochkareva, L. Kaustov, A. Ayed, G.S. Yi, Y. Lu, A. Pineda-Lucena, J.C. Liao, A.L. Okorokov, J. Milner, C.H. Arrowsmith, and A. Bochkarev Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A Proc. Natl. Acad. Sci. USA 102 2005 15412 15417
36. J.P. Rowell, K.L. Simpson, K. Stott, M. Watson, and J.O. Thomas HMGB1-facilitated p53 DNA binding occurs via HMG-Box/p53 transactivation domain interaction, regulated by the acidic tail Structure 20 2012 2014 2024
37. P. Di Lello, L.M. Jenkins, T.N. Jones, B.D. Nguyen, T. Hara, H. Yamaguchi, J.D. Dikeakos, E. Appella, P. Legault, and J.G. Omichinski Structure of the Tfb1/p53 complex: insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53 Mol. Cell 22 2006 731 740
38. S. Lukhele, A. Bah, H. Lin, N. Sonenberg, and J.D. Forman-Kay Interaction of the eukaryotic initiation factor 4E with 4E-BP2 at a dynamic bipartite interface Structure 21 2013 2186 2196
39. K.S. Paku, Y. Umenaga, T. Usui, A. Fukuyo, A. Mizuno, Y. In, T. Ishida, and K. Tomoo A conserved motif within the flexible C-terminus of the translational regulator 4E-BP is required for tight binding to the mRNA cap-binding protein eIF4E Biochem. J. 441 2012 237 245
40. H.N. Motlagh, J.O. Wrabl, J. Li, and V.J. Hilser The ensemble nature of allostery Nature 508 2014 331 339
41. V.J. Hilser, and E.B. Thompson Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins Proc. Natl. Acad. Sci. USA 104 2007 8311 8315
42. A.C. Ferreon, J.C. Ferreon, P.E. Wright, and A.A. Deniz Modulation of allostery by protein intrinsic disorder Nature 498 2013 390 394
43. A. Garcia-Pino, S. Balasubramanian, L. Wyns, E. Gazit, H. De Greve, R.D. Magnuson, D. Charlier, N.A. van Nuland, and R. Loris Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity Cell 142 2010 101 111
44. V.J. Hilser, and E.B. Thompson Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors J. Biol. Chem. 286 2011 39675 39682
45. H.N. Motlagh, J. Li, E.B. Thompson, and V.J. Hilser Interplay between allostery and intrinsic disorder in an ensemble Biochem. Soc. Trans. 40 2012 975 980
46. J.O. Wrabl, J. Gu, T. Liu, T.P. Schrank, S.T. Whitten, and V.J. Hilser The role of protein conformational fluctuations in allostery, function, and evolution Biophys. Chem. 159 2011 129 141
47. E. White Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus Oncogene 20 2001 7836 7846
48. J.C. Ferreon, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein Proc. Natl. Acad. Sci. USA 106 2009 13260 13265
49. R. Ferrari, M. Pellegrini, G.A. Horwitz, W. Xie, A.J. Berk, and S.K. Kurdistani Epigenetic reprogramming by adenovirus e1a Science 321 2008 1086 1088
50. J. Dogan, S. Gianni, and P. Jemth The binding mechanisms of intrinsically disordered proteins Phys. Chem. Chem. Phys. 16 2014 6323 6331
51. H.X. Zhou Intrinsic disorder: signaling via highly specific but short-lived association Trends Biochem. Sci. 37 2012 43 48
52. H.X. Zhou, X. Pang, and C. Lu Rate constants and mechanisms of intrinsically disordered proteins binding to structured targets Phys. Chem. Chem. Phys. 14 2012 10466 10476
53. A. Binolfi, F.X. Theillet, and P. Selenko Bacterial in-cell NMR of human alpha-synuclein: a disordered monomer by nature? Biochem. Soc. Trans. 40 2012 950 954
54. J.D. Forman-Kay, and T. Mittag From sequence and forces to structure, function, and evolution of intrinsically disordered proteins Structure 21 2013 1492 1499
55. A.E. Smith, L.Z. Zhou, and G.J. Pielak Hydrogen exchange of disordered proteins in Escherichia coli Protein Sci. 24 2015 706 713
56. F.X. Theillet, A. Binolfi, T. Frembgen-Kesner, K. Hingorani, M. Sarkar, C. Kyne, C. Li, P.B. Crowley, L. Gierasch, G.J. Pielak, A.H. Elcock, A. Gershenson, and P. Selenko Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs) Chem. Rev. 114 2014 6661 6714
57. G.W. Daughdrill, L.J. Hanely, and F.W. Dahlquist The C-terminal half of the anti-sigma factor FlgM contains a dynamic equilibrium solution structure favoring helical conformations Biochemistry 37 1998 1076 1082
58. C.K. Fisher, and C.M. Stultz Constructing ensembles for intrinsically disordered proteins Curr. Opin. Struct. Biol. 21 2011 426 431
59. L.M. Espinoza-Fonseca Reconciling binding mechanisms of intrinsically disordered proteins Biochem. Biophys. Res. Commun. 382 2009 479 482
60. G.G. Hammes, Y.C. Chang, and T.G. Oas Conformational selection or induced fit: a flux description of reaction mechanism Proc. Natl. Acad. Sci. USA 106 2009 13737 13741
61. M. Fuxreiter, I. Simon, P. Friedrich, and P. Tompa Preformed structural elements feature in partner recognition by intrinsically unstructured proteins J. Mol. Biol. 338 2004 1015 1026
62. C.J. Oldfield, J. Meng, J.Y. Yang, M.Q. Yang, V.N. Uversky, and A.K. Dunker Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners BMC Genomics 9 Suppl. 1 2008 S1
63. S. Gianni, A. Morrone, R. Giri, and M. Brunori A folding-after-binding mechanism describes the recognition between the transactivation domain of c-Myb and the KIX domain of the CREB-binding protein Biochem. Biophys. Res. Commun. 428 2012 205 209
64. J.M. Rogers, C.T. Wong, and J. Clarke Coupled folding and binding of the disordered protein PUMA does not require particular residual structure J. Am. Chem. Soc. 136 2014 5197 5200
65. S.L. Shammas, A.J. Travis, and J. Clarke Remarkably fast coupled folding and binding of the intrinsically disordered transactivation domain of cMyb to CBP KIX J. Phys. Chem. B 117 2013 13346 13356
66. S.L. Shammas, A.J. Travis, and J. Clarke Allostery within a transcription coactivator is predominantly mediated through dissociation rate constants Proc. Natl. Acad. Sci. USA 111 2014 12055 12060
67. K. Sugase, H.J. Dyson, and P.E. Wright Mechanism of coupled folding and binding of an intrinsically disordered protein Nature 447 2007 1021 1025
68. W. Borcherds, F.X. Theillet, A. Katzer, A. Finzel, K.M. Mishall, A.T. Powell, H. Wu, W. Manieri, C. Dieterich, P. Selenko, A. Loewer, and G.W. Daughdrill Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells Nat. Chem. Biol. 10 2014 1000 1002
69. V. Iesmantavicius, J. Dogan, P. Jemth, K. Teilum, and M. Kjaergaard Helical propensity in an intrinsically disordered protein accelerates ligand binding Angew. Chem. 53 2014 1548 1551
70. S. Otieno, and R. Kriwacki Probing the role of nascent helicity in p27 function as a cell cycle regulator PLoS One 7 2012 e47177
71. R. Schneider, D. Maurin, G. Communie, J. Kragelj, D.F. Hansen, R.W. Ruigrok, M.R. Jensen, and M. Blackledge Visualizing the molecular recognition trajectory of an intrinsically disordered protein using multinuclear relaxation dispersion NMR J. Am. Chem. Soc. 137 2015 1220 1229
72. K. Sugase, J.C. Lansing, H.J. Dyson, and P.E. Wright Tailoring relaxation dispersion experiments for fast-associating protein complexes J. Am. Chem. Soc. 129 2007 13406 13407
73. M. Dosnon, D. Bonetti, A. Morrone, J. Erales, E. di Silvio, S. Longhi, and S. Gianni Demonstration of a folding after binding mechanism in the recognition between the measles virus NTAIL and X domains ACS Chem. Biol. 10 2015 795 802
74. G.L. Semenza Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology Trends Mol. Med. 7 2001 345 350
75. J.M. Elkins, K.S. Hewitson, L.A. McNeill, J.F. Seibel, I. Schlemminger, C.W. Pugh, P.J. Ratcliffe, and C.J. Schofield Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha J. Biol. Chem. 278 2003 1802 1806
76. D. Lando, D.J. Peet, D.A. Whelan, J.J. Gorman, and M.L. Whitelaw Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch Science 295 2002 858 861
77. S.A. Dames, M. Martinez-Yamout, R.N. De Guzman, H.J. Dyson, and P.E. Wright Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response Proc. Natl. Acad. Sci. USA 99 2002 5271 5276
78. S.J. Freedman, Z.Y. Sun, F. Poy, A.L. Kung, D.M. Livingston, G. Wagner, and M.J. Eck Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha Proc. Natl. Acad. Sci. USA 99 2002 5367 5372
79. O.N. Jensen Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry Curr. Opin. Chem. Biol. 8 2004 33 41
80. L.M. Iakoucheva, P. Radivojac, C.J. Brown, T.R. O'Connor, J.G. Sikes, Z. Obradovic, and A.K. Dunker The importance of intrinsic disorder for protein phosphorylation Nucleic Acids Res. 32 2004 1037 1049
81. J.C. Chrivia, R.P. Kwok, N. Lamb, M. Hagiwara, M.R. Montminy, and R.H. Goodman Phosphorylated CREB binds specifically to the nuclear protein CBP Nature 365 1993 855 859
82. I. Radhakrishnan, G.C. Perez-Alvarado, D. Parker, H.J. Dyson, M.R. Montminy, and P.E. Wright Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions Cell 91 1997 741 752
83. C.W. Lee, J.C. Ferreon, A.C. Ferreon, M. Arai, and P.E. Wright Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation Proc. Natl. Acad. Sci. USA 107 2010 19290 19295
84. O. Schon, A. Friedler, M. Bycroft, S.M. Freund, and A.R. Fersht Molecular mechanism of the interaction between MDM2 and p53 J. Mol. Biol. 323 2002 491 501
85. V. Pejaver, W.L. Hsu, F. Xin, A.K. Dunker, V.N. Uversky, and P. Radivojac The structural and functional signatures of proteins that undergo multiple events of post-translational modification Protein Sci. 23 2014 1077 1093
86. R.K. Das, and R.V. Pappu Conformations of intrinsically disordered proteins are influenced by linear sequence distributions of oppositely charged residues Proc. Natl. Acad. Sci. USA 110 2013 13392 13397
87. D.W. Meek, and D.M. Milne Analysis of multisite phosphorylation of the p53 tumor-suppressor protein by tryptic phosphopeptide mapping Methods Mol. Biol. 99 2000 447 463
88. D.M. Mitrea, C.R. Grace, M. Buljan, M.K. Yun, N.J. Pytel, J. Satumba, A. Nourse, C.G. Park, M. Madan Babu, S.W. White, and R.W. Kriwacki Structural polymorphism in the N-terminal oligomerization domain of NPM1 Proc. Natl. Acad. Sci. USA 111 2014 4466 4471
89. D.M. Mitrea, and R.W. Kriwacki Cryptic disorder: an order-disorder transformation regulates the function of nucleophosmin Pac. Symp. Biocomputing 2012 152 163
90. L.M. Espinoza-Fonseca, D. Kast, and D.D. Thomas Thermodynamic and structural basis of phosphorylation-induced disorder-to-order transition in the regulatory light chain of smooth muscle myosin J. Am. Chem. Soc. 130 2008 12208 12209
91. A. Bah, R.M. Vernon, Z. Siddiqui, M. Krzeminski, R. Muhandiram, C. Zhao, N. Sonenberg, L.E. Kay, and J.D. Forman-Kay Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch Nature 519 2015 106 109
92. C.M. Fletcher, A.M. McGuire, A.C. Gingras, H. Li, H. Matsuo, N. Sonenberg, and G. Wagner 4E binding proteins inhibit the translation factor eIF4E without folded structure Biochemistry 37 1998 9 15
93. N. Sonenberg, and A.G. Hinnebusch Regulation of translation initiation in eukaryotes: mechanisms and biological targets Cell 136 2009 731 745
94. C. Bieniossek, T. Imasaki, Y. Takagi, and I. Berger MultiBac: expanding the research toolbox for multiprotein complexes Trends Biochem. Sci. 37 2012 49 57
95. H. Yumerefendi, F. Tarendeau, P.J. Mas, and D.J. Hart ESPRIT: an automated, library-based method for mapping and soluble expression of protein domains from challenging targets J. Struct. Biol. 172 2010 66 74
96. F. Katzen, G. Chang, and W. Kudlicki The past, present and future of cell-free protein synthesis Trends Biotechnol. 23 2005 150 156
97. A. Kurotani, T. Takagi, M. Toyama, M. Shirouzu, S. Yokoyama, Y. Fukami, and A.A. Tokmakov Comprehensive bioinformatics analysis of cell-free protein synthesis: identification of multiple protein properties that correlate with successful expression FASEB J. 24 2010 1095 1104
98. P. Lundstrom, P. Vallurupalli, D.F. Hansen, and L.E. Kay Isotope labeling methods for studies of excited protein states by relaxation dispersion NMR spectroscopy Nat. Protoc. 4 2009 1641 1648
99. V. Tugarinov, V. Kanelis, and L.E. Kay Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy Nat. Protoc. 1 2006 749 754
100. N.H. Shah, and T.W. Muir Inteins: Nature's Gift to Protein Chemists Chem. Sci. 5 2014 446 461
101. A.C. Ferreon, C.R. Moran, Y. Gambin, and A.A. Deniz Single-molecule fluorescence studies of intrinsically disordered proteins Methods Enzymol. 472 2010 179 204
102. J.C. Gebhardt, D.M. Suter, R. Roy, Z.W. Zhao, A.R. Chapman, S. Basu, T. Maniatis, and X.S. Xie Single-molecule imaging of transcription factor binding to DNA in live mammalian cells Nat. Methods 10 2013 421 426
103. J.J. Sakon, and K.R. Weninger Detecting the conformation of individual proteins in live cells Nat. Methods 7 2010 203 205
104. P. Selenko, D.P. Frueh, S.J. Elsaesser, W. Haas, S.P. Gygi, and G. Wagner In situ observation of protein phosphorylation by high-resolution NMR spectroscopy Nat. Struct. Mol. Biol. 15 2008 321 329
105. A.L. Hopkins, and C.R. Groom The druggable genome Nat. Rev. Drug Discov. 1 2002 727 730
106. G. Zinzalla, and D.E. Thurston Targeting protein-protein interactions for therapeutic intervention: a challenge for the future Future Med. Chem. 1 2009 65 93
107. L. Chen, W. Borcherds, S. Wu, A. Becker, E. Schonbrunn, G.W. Daughdrill, and J. Chen Autoinhibition of MDMX by intramolecular p53 mimicry Proc. Natl. Acad. Sci. USA 2015
108. B.B. Lao, K. Drew, D.A. Guarracino, T.F. Brewer, D.W. Heindel, R. Bonneau, and P.S. Arora Rational design of topographical helix mimics as potent inhibitors of protein-protein interactions J. Am. Chem. Soc. 136 2014 7877 7888
109. B.B. Lao, I. Grishagin, H. Mesallati, T.F. Brewer, B.Z. Olenyuk, and P.S. Arora In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics Proc. Natl. Acad. Sci. USA 111 2014 7531 7536
110. S. Shangary, and S. Wang Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy Annu. Rev. Pharmacol. Toxicol. 49 2009 223 241
111. S. Yu, D. Qin, S. Shangary, J. Chen, G. Wang, K. Ding, D. McEachern, S. Qiu, Z. Nikolovska-Coleska, R. Miller, S. Kang, D. Yang, and S. Wang Potent and orally active small-molecule inhibitors of the MDM2-p53 interaction J. Med. Chem. 52 2009 7970 7973
112. D.I. Hammoudeh, A.V. Follis, E.V. Prochownik, and S.J. Metallo Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc J. Am. Chem. Soc. 131 2009 7390 7401
113. N. Krishnan, D. Koveal, D.H. Miller, B. Xue, S.D. Akshinthala, J. Kragelj, M.R. Jensen, C.M. Gauss, R. Page, M. Blackledge, S.K. Muthuswamy, W. Peti, and N.K. Tonks Targeting the disordered C terminus of PTP1B with an allosteric inhibitor Nat. Chem. Biol. 10 2014 558 566